Northwestern Mutual Wealth Management CO Eli Lilly & CO Transaction History

Northwestern Mutual Wealth Management CO

$112 Billion
Q3 2024

A detailed history of Northwestern Mutual Wealth Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 190,648 shares of LLY stock, worth $152 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

190,648

Previous 154,106 23.71%

Holding current value

$152 Million

Previous $140 Million 21.06%

% of portfolio

0.15%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $28.2 Million - $35.1 Million	36,542 Added 23.71%	190,648 $169 Million
Q2 2024 Aug 15, 2024	BUY	$724.87 - $909.04 $5.21 Million - $6.53 Million	7,183 Added 4.89%	154,106 $140 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $1.8 Million - $2.4 Million	-3,035 Reduced 2.02%	146,923 $114 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $7.14 Million - $8.42 Million	13,602 Added 9.98%	149,958 $87.4 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $23.6 Million - $32.5 Million	54,313 Added 66.2%	136,356 $73.2 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1.16 Million - $1.56 Million	3,319 Added 4.22%	82,043 $38.5 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $370,892 - $435,595	1,194 Added 1.54%	78,724 $27 Million
Q4 2022 Feb 21, 2023	SELL	$321.55 - $374.67 $1.42 Million - $1.65 Million	-4,417 Reduced 5.39%	77,530 $28.4 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $353,107 - $402,403	1,191 Added 1.47%	81,947 $26.5 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $390,222 - $458,178	1,400 Added 1.76%	80,756 $26.2 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $582,265 - $723,608	-2,481 Reduced 3.03%	79,356 $22.7 Million
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $2.24 Million - $2.78 Million	9,954 Added 13.85%	81,837 $22.6 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $299,381 - $368,431	1,351 Added 1.92%	71,883 $16.6 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $1.17 Million - $1.51 Million	6,457 Added 10.08%	70,532 $16.2 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $149,695 - $193,787	911 Added 1.44%	64,075 $12 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $13,567 - $17,953	104 Added 0.16%	63,164 $10.7 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $467,611 - $540,877	3,198 Added 5.34%	63,060 $9.33 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $170,115 - $204,732	-1,247 Reduced 2.04%	59,862 $9.83 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $145,955 - $180,651	-1,226 Reduced 1.97%	61,109 $8.48 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $547,323 - $677,909	-5,119 Reduced 7.59%	62,335 $8.19 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $120,459 - $131,028	-1,128 Reduced 1.64%	67,454 $7.54 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $393,969 - $459,861	-3,556 Reduced 4.93%	68,582 $7.6 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $999,452 - $1.18 Million	-8,979 Reduced 11.07%	72,138 $9.36 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $1.07 Million - $1.2 Million	10,101 Added 14.22%	81,117 $9.39 Million
Q3 2018 Nov 01, 2018	SELL	$85.86 - $107.31 $242,983 - $303,687	-2,830 Reduced 3.83%	71,016 $7.62 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $253,367 - $290,787	-3,347 Reduced 4.34%	73,846 $6.3 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $521,696 - $615,828	7,030 Added 10.02%	77,193 $5.97 Million
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $307,848 - $330,202	-3,757 Reduced 5.08%	70,163 $5.93 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $241,999 - $268,595	3,140 Added 4.44%	73,920 $6.32 Million
Q2 2017 Aug 10, 2017	BUY	N/A	70,780	70,780 $5.83 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Account

Northwestern Mutual Wealth Management CO Eli Lilly & CO Transaction History